| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.097 | 0.02 |